Reports

• CMS Has Opportunities To Strengthen States Oversight of Medicaid Managed Care Plans Reporting of Medical Loss Ratios

  

• FDA Repeatedly Adapted Emergency Use Authorization Policies To Address the Need for COVID-19 Testing

  

• FDA Work with the Tri-Agency Task Force for Emergency Diagnostics Helped Labs Implement COVID-19 Tests

  

• Nearly All States Made Capitation Payments for Beneficiaries Who Were Concurrently Enrolled in a Medicaid Managed Care Program in Two States

  

• Medicare Part B Overpaid and Beneficiaries Incurred Cost-Share Overcharges of Over $1 Million for the Same Professional Services

  

• IHS National Supply Service Center Was Generally Effective in Providing Supplies to Facilities During the COVID-19 Pandemic, but Its Internal Controls Could Be Improved

  

• Advisory Opinion 22-18

  

• Opioid Overdoses and the Limited Treatment of Opioid Use Disorder Continue To Be Concerns for Medicare Beneficiaries

  

• Tennessee Did Not Always Invoice Rebates to Manufacturers for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations

  

• Medicare Advantage Compliance Audit of Specific Diagnosis Codes That Regence BlueCross BlueShield of Oregon (Contract H3817) Submitted to CMS

  

• New York Claimed $196 Million, Over 72 Percent of the Audited Amount, in Federal Reimbursement for NEMT Payments to New York City Transportation Providers That Did Not Meet or May Not Have Met Medicaid Requirements

  

• The IHS Telehealth System Was Deployed Without Some Required Cybersecurity Controls

  

• Medicare Telehealth Services During the First Year of the Pandemic: Program Integrity Risks

  

• Certain Medicare Beneficiaries, Such as Urban and Hispanic Beneficiaries, Were More Likely Than Others To Use Telehealth During the First Year of the COVID-19 Pandemic

  

• Reducing Medicare Payment Rates for Intermittent Urinary Catheters Can Save the Program and Beneficiaries Millions of Dollars Each Year

  

• Foreign Assistance to Combat HIV/AIDS, Tuberculosis, and Malaria Fiscal Year 2023 Inspectors General Coordinated PEPFAR Oversight Plan U.S. Department of Health and Human Services, Office of Inspector General

  

• Medicare Advantage Compliance Audit of Specific Diagnosis Codes That WellCare of Florida, Inc., (Contract H1032) Submitted to CMS

  

• Montana Claimed Federal Medicaid Reimbursement for More Than $5 Million in Targeted Case Management Services That Did Not Comply With Federal and State Requirements

  

• Medicare Advantage Compliance Audit of Diagnosis Codes That Cigna HealthSpring of Florida, Inc. (Contract H5410) Submitted to CMS

  

• Advisory Opinion 22-16